Medinotec Inc. (MDNC)

OTC Markets OTCQX

$5.000.00% today

Price as at 2 Oct 2026, 12:57 UTC. Quotes are delayed.

Fundamentals

52-week range$5.00 to $5.00

Valuation and ratings

Medinotec Inc. trades at $5.00. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.

About Medinotec Inc.

Medinotec Inc. engages in the research and development, production, and sale of medical devices used in cardiology and airway-related procedures in South Africa, the United States, and internationally. The company offers semi-compliant percutaneous transluminal coronary angioplasty balloon catheters, suction dissectors, aortic perfusion and dilation catheters, chronic total occlusion catheters, and silicone tracheal stents; and distributes a range of cardiology and renal dialysis products. It serves hospitals, clinics, third-party healthcare providers, distributors, and other institutions, including governmental healthcare programs and group purchasing organizations. The company sells its products through the network of distributors and direct sales force. Medinotec Inc. was incorporated in 2021 and is headquartered in Johannesburg, South Africa.

Industry: Medical DevicesEmployees: 36HQ: South Africa

Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.

Common questions

Where does SteadyShares get its MDNC data?

Fundamentals for MDNC come from company filings and exchange data, as listed on OTC Markets OTCQX; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 2 Oct 2026, 12:57 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.

The full research page for MDNC, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.

Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.